George C. Prendergast, PhD, became the president and CEO of the Lankenau
Institute for Medical Research (LIMR) in December 2004.
Prendergast is a graduate of the University of Pennsylvania, where he
received a Bachelor's degree in Biochemistry. He received his Master’s
degree in Molecular Biophysics and Biochemistry from Yale University and
his doctorate in Molecular Biology from Princeton University.
He went on to obtain advanced training as an American Cancer Society
postdoctoral fellow at the Howard Hughes Medical Institute at NYU
Medical Center, after which he joined the Department of Cancer Research
at Merck Research Laboratories.
In 1993, Prendergast was appointed assistant professor and later
associate professor at The Wistar Institute in Philadelphia, where he
was designated a Pew Scholar in the biomedical sciences. Subsequently,
he became senior director of the Cancer Research Group at the DuPont
Pharmaceutical Company. In 2002, he moved his research efforts at Wistar
and DuPont to LIMR, where he was appointed to the faculty as a senior
investigator.
Along the way, Prendergast has received numerous honors and recognitions
and has a world-class reputation in his field.
Prendergast and his family reside in Penn Valley, PA.
1.866.CALL.MLH
or 484.580.1000
